Tekla Capital Management LLC Travere Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$18.47 - $26.14 $3.16 Million - $4.47 Million
170,842 Added 68.98%
418,520 $8.8 Million
Q1 2022

May 13, 2022
BUY
$23.61 - $30.6 $821,840 - $1.07 Million
34,809 Added 16.35%
247,678 $6.38 Million
Q1 2021

May 14, 2021
BUY
$23.37 - $31.77 $4.97 Million - $6.76 Million
212,869 New
212,869 $5.32 Million

Others Institutions Holding TVTX

# of Institutions
203
Shares Held
85.2M
Call Options Held
776K
Put Options Held
912K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.4B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email